Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | — | 30.9B | 25.7B | 25.5B |
Cost of revenue | — | 22.9B | 18.4B | 17.8B |
Gross profit | 6.7B | 8.0B | 7.3B | 7.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.6B | 5.9B | 5.5B | 5.4B |
Other operating expenses | — | — | — | — |
Operating income | — | 1.5B | 1.2B | 1.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 116M | 90M | 105M | 110M |
Other income expense | 26M | 29M | 28M | 20M |
Pretax income | — | 1.4B | 1.1B | 1.5B |
Tax provision | 346M | 303M | 237M | 353M |
Net income | 1.0B | 1.1B | 854M | 1.2B |
Basic EPS | — | — | 1.9 | 2.6 |
Diluted EPS | — | — | 1.9 | 2.6 |
Basic average shares | 455M | 456.8M | 460.1M | 462.5M |
Diluted average shares | 456.5M | 458.4M | 461.5M | 463.5M |
EBITDA | 2.3B | 2.3B | 2.0B | 2.4B |
Net income from continuing op. | — | 1.1B | 854M | 1.2B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |